STAT+: Japanese conglomerate to buy Calliditas Therapeutics, maker of a kidney disease drug
LONDON — Seeking to build up its pharma business, the Japanese conglomerate Asahi Kasei is…
Category: Medicine
At Las Vegas conference, methadone clinics blast idea of doctors prescribing directly
LAS VEGAS — Mark Parrino, the longtime leader of the U.S. methadone clinic industry, kicked…
Opinion: Achieving telehealth equity for people with hearing loss
Gen Z has made captioning cool. Captions are now widely available in social media, entertainment…
STAT+: Gene therapies for deafness dredge up an old question: Do deaf people want a ‘cure’?
When Yilai Shu was training to be an otolaryngologist in Shanghai, in the mid 2000s,…
The doctor would treat her sickle cell pain crisis — if she promised not to get an abortion
Here are some things A. was told when she arrived at the hospital one night…
STAT+: Duchenne muscular dystrophy drug from Nippon Shinyaku fails in rare confirmatory trial
Japanese drugmaker Nippon Shinyaku said on Monday that its Duchenne muscular dystrophy drug, Viltepso, part…
.jpg)
Opinion: The world needs the new pandemic treaty
At the height of the Covid-19 pandemic, 25 heads of government issued an extraordinary call…
STAT+: ASCO preview: a promising solid tumor CAR-T, an AI patient navigator, and improving palliative care
Thousands of cancer researchers and clinicians are flocking to Chicago for the American Society of…
STAT+: Nursing homes sue over Biden administration’s minimum staffing rule
A new federal lawsuit challenging the Biden administration’s new minimum nursing home staffing rule lays…
New evidence supports fear that drinking raw milk containing bird flu viruses may be dangerous
A new study published Friday provides more evidence of the potential danger of drinking unpasteurized,…
STAT+: Pharmalittle: We’re watching more positive data for Ozempic, a Lilly factory expansion, and more
It’s an honor to fill in for Ed Silverman this morning. There is only one…
More tumult at BIO amid the company’s fourth CEO in four years
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Ozempic cut risk of death in diabetes patients with chronic kidney disease
Novo Nordisk’s Ozempic cut the risk of death in a trial of patients with type…
STAT+: After MDMA therapy, she considered suicide. The trial data tell a different story
The MDMA study was her last hope. She had read headlines celebrating a 83% response…
Opinion: Pandemic lessons must spur federal action to protect nursing home residents
About one-third of Americans who reach age 65 will need nursing home care in their…
Opinion: STAT+: Unmasking the ‘centricity’ illusion in clinical trials
During my 25 years working in clinical trial operations, I’ve seen the biopharmaceutical world talk…
STAT+: FDA advisers endorse Guardant Health’s colon cancer screening test
An independent panel of advisers to the Food and Drug Administration recommended the agency approve…
STAT+: Ahead of ASCO, J&J reports mixed data on next-generation radiopharmaceutical
An early-stage clinical trial of a radiopharmaceutical drug developed by Johnson & Johnson showed some…
The HPV vaccine prevents cancer in men, too. Why do so few people get it?
You’d think if there were a vaccine that would prevent tens of thousands of cases…
STAT+: Pharma’s losing bet in New Jersey
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and…
Louisiana legislature approves bill classifying abortion pills as controlled dangerous substances
BATON ROUGE — Two abortion-inducing drugs could soon be reclassified as controlled and dangerous substances…
Listen: More tumult at BIO & coercive care for sickle cell patients
How does a drug industry lobbying group move forward after years of upheaval, including having…
Reversing progress, stroke rates are rising, especially in working-age adults
Stroke prevalence has been climbing over the past decade, reversing a steady decline among all…
In light of H5N1 outbreak, U.S. in talks with mRNA vaccine makers on bird flu
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Pharmalittle: We’re watching a Cytokinetics deal with Royalty Pharma, Cue Health shutting down, and more
Top of the morning to you. I’m filling in for Ed Silverman this morning, which…
STAT+: Setting the table: What to expect at this year’s ASCO meeting
This is the online edition of Adam’s Biotech Scorecard, a subscriber-only newsletter. STAT+ subscribers can…
STAT+: Cytokinetics CEO Robert Blum is on my Worst CEO shortlist again, and other thoughts
Thoughts about Cytokinetics after Wednesday night’s financing announcement: 1. Management is raising $500 million at…
STAT+: Biotechs turn to gene silencing for obesity drugs that can last longer than Wegovy
Enticed by the immense market opened by GLP-1 weight loss drugs Wegovy and Zepbound, a…
Opinion: Addressing health care workers’ trauma can help fight burnout
Burnout is a growing crisis in health care: More than 50% of health care professionals…
Fresh scrutiny of post-Covid spending reignites yearslong tension over emergency stockpiles
WASHINGTON — For four years, Democrats and Republicans have routinely clashed over funding to curb…
Opinion: Making the case for fair compensation in clinical trials
I’ve been on three sides of the health care equation: I’ve beaten stage 4 colorectal…
Wastewater testing specifically for bird flu virus will scale up nationally in coming weeks
Less than a month ago, researchers reported for the first time the ability to scan…
STAT+: Cytokinetics sells Royalty Pharma a share of its heart drug for up to $575 million, lowering hopes of a buyout
Cytokinetics, a drugmaker that is expected to soon launch a promising new heart therapy called…
STAT+: Cue Health, Covid-19 testing company, is shutting down
In an abrupt change of course from plans earlier in the month, at-home test maker…
.jpg)
STAT+: FDA poised to publish guidelines for clinical trial diversity
The Food and Drug Administration is poised to tell drug and medical device makers how…
Michigan reports a human case of H5N1 bird flu, the nation’s second linked to outbreak in dairy cows
A second human case of H5N1 bird flu infection linked to the current outbreak in…
STAT+: New antiviral works against coronaviruses in mice, but human testing will have to wait
During the Covid-19 pandemic, vaccines were the main line of defense. Startlingly effective shots quickly…
UnitedHealth argues algorithm lawsuit should be dismissed because patients didn’t spend years appealing denials
UnitedHealth Group should be released from a lawsuit that alleges its algorithm-based technology prematurely cut…
STAT+: Eyeing GLP-1 opportunity, Click buys assets of Better Therapeutics
Digital therapeutics company Click Therapeutics announced Wednesday it will acquire the assets of Better Therapeutics,…
Maryland takes first steps to cap drug costs
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Pharmalittle: We’re watching a ban compounded versions of GLP-1s, a Biogen acquisition, and more
Good morning from San Diego. This is Jonathan Wosen, West Coast biotech and life sciences…
STAT+: Biogen joins immunology wave with $1.15 billion acquisition
Biogen is joining the industry’s fervor over immune and inflammatory disease drug development with a…
Listen: A conversation with researcher Kevin Esvelt on the urgency of improving biosecurity measures
If you ask a chatbot how to cause a pandemic, it will suggest the 1918…
When should we start making H5N1 vaccine, and who will make that decision? In short, it’s complicated
If the H5N1 bird flu virus ever acquires the ability to transmit easily to and…
Off-label treatment for alcohol use disorder is linked to slower liver decline, study suggests
WASHINGTON — There are three FDA-approved drugs for treating alcohol use disorder. But a different…
Opinion: Digital health: a case of mistaken identity
History and literature are replete with cautionary tales on the dangers of pretending to be…
Opinion: What clinical real-world data can deliver
Thanks to new regulatory frameworks like the Food and Drug Administration’s Breakthrough Therapy designation, drugs…
CDC asks states and cities to keep flu surveillance at peak levels because of bird flu threat
The Centers for Disease Control and Prevention asked local and state health officials Tuesday to…
‘Coercive Care’ investigation reveals how doctors have pressured sickle cell patients into unwanted sterilizations
Dear Readers, I want to bring your attention to a deeply disturbing but vital series…
STAT+: Pharmalittle: We’re watching BIO layoffs, AstraZeneca plans to double revenue, and more
Good morning from the Pharmalittle campus, where I’m filling in for Ed. Normally, I’m the…